# Oramed Pharmaceuticals Inc.: Form 8-K, filed Jul 13, 2023

- Company: [Oramed Pharmaceuticals Inc.](/companies/ormp.md) (CIK 1176309)
- Form: 8-K
- Filed: 2023-07-13
- Accepted by EDGAR: Jul 13, 2023, 17:00 ET
- Period: 2023-07-13
- Accession: 0001213900-23-056806
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1176309/000121390023056806/ea181769-8k_oramedpharm.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1176309/000121390023056806/

## Items reported

- Item 5.07: Shareholder vote results

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1176309/000121390023056806/ea181769-8k_oramedpharm.htm

Filed Jul 13, 2023.
Source: SEC EDGAR, the filing index for accession 0001213900-23-056806. Last ingested by Listed: Nov 15, 2026, 04:14 ET. No prices; not investment advice.
